A significant shift has occurred among Bayer's major shareholders, with activist investor Jeff Ubben deciding to divest his stake. His firm, Inclusive Capital Partners, sold a multi-million share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results